50 SPXIQ

LLY Eli Lilly and Company

Healthcare · Drug Manufacturers - General

$1049.26 +15.7% upside
Mean Target
$1214.34
Consensus
1.7 - Buy
Analysts
29
Rank
#262 / 499
Upside Rank
#182
Analyst Price Target Distribution
$870
Low
$1250
Median
$1214
Mean
$1500
High
Current $1049
Mean $1214
Median $1250
99 estimates
Consensus
1.7 - Buy
52-Wk Low
$623.78
52-Wk High
$1133.95
50-Day Avg
$1053.09
Recent Analyst Ratings
FirmRatingTargetPriorDate
RBC Capital Outperform $1250 — 2026-02-25
Barclays Overweight $1350 — 2026-02-20
Deutsche Bank Buy $1285 $1200 2026-02-09
JP Morgan Overweight $1300 $1150 2026-02-05
Cantor Fitzgerald Overweight $1205 $985 2026-02-05
Healthcare Peers
ABT ABBV A ALGN AMGN BAX BDX TECH BIIB BSX BMY CAH CNC COR CRL CI COO CVS DHR DVA DXCM EW ELV GEHC